Advertisement

Topics

Indivior presents Phase III data on sustained-release opioid addiction therapy

06:45 EDT 23 Jun 2017 | thePharmaLetter

UK-based Indivior has presented Phase III results from a trial into RBP-6000, an investigational once-monthly…

Original Article: Indivior presents Phase III data on sustained-release opioid addiction therapy

NEXT ARTICLE

More From BioPortfolio on "Indivior presents Phase III data on sustained-release opioid addiction therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...